Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bradykinin antagonists: new opportunities.

M G Bock1, J Longmore

  • 1Merck Research Laboratories, West Point, PA 19486, USA. mark_bock@merck.com

Current Opinion in Chemical Biology
|August 26, 2000
PubMed
Summary

Bradykinin B1 and B2 receptor antagonists show potential as anti-inflammatory and analgesic drugs. Further research is needed to explore their full clinical utility and develop new therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phormium Yellow Leaf Phytoplasma Is Associated with Strawberry Lethal Yellows Disease in New Zealand.

Plant disease·2019
Same author

An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres.

Cephalalgia : an international journal of headache·2002
Same author

5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.

British journal of clinical pharmacology·2002
Same author

CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.

British journal of pharmacology·2001
Same author

5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase.

Brain research·2001
Same author

Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.

Bioorganic & medicinal chemistry letters·2001

Area of Science:

  • Pharmacology
  • Inflammation Research
  • Pain Management

Background:

  • Bradykinin B2 receptor activation is known to cause inflammation, pain, and cardiovascular effects.
  • Bradykinin B1 receptors are also implicated in inflammatory and pain pathways.

Purpose of the Study:

  • To evaluate the potential of bradykinin receptor antagonists as anti-inflammatory and analgesic drugs.
  • To explore other potential clinical applications for these antagonists.

Main Methods:

  • Utilizing newly discovered non-peptide B2 receptor antagonists.
  • Employing pharmacological agents targeting B1 receptors currently in development.

Main Results:

  • Antagonists are anticipated to possess anti-inflammatory and analgesic properties.
  • Preclinical tools are available for evaluating potential therapeutic utilities.

Conclusions:

  • Bradykinin receptor antagonists represent a promising class of drugs for managing inflammation and pain.
  • Further investigation into B1 and B2 receptor antagonists may reveal novel clinical opportunities.

Related Experiment Videos